| Patent | Date |
|---|
Display Apparatus
App 20220122508 - Chang; Chien-Hsing | 2022-04-21 |
Touch structure, manufacturing method thereof, and touch display device
Grant 11,269,434 - Chang March 8, 2 | 2022-03-08 |
Display Device
App 20210305462 - CHANG; Chien-Hsing | 2021-09-30 |
Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes resistance to SN-38 in Trop-2 expressing cancers
Grant 10,954,305 - Chang , et al. March 23, 2 | 2021-03-23 |
Touch Structure, Manufacturing Method Thereof, And Touch Display Device
App 20200371628 - Chang; Chien-Hsing | 2020-11-26 |
Reflective Active Device Array Substrate And Manufacturing Method Thereof And Reflective Display Apparatus And Manufacturing Method Thereof
App 20200341344 - Chang; Chien-Hsing | 2020-10-29 |
Anti-PD-1 checkpoint inhibitor antibodies that block binding of PD-L1 to PD-1
Grant 10,669,338 - Chang , et al. | 2020-06-02 |
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 10,662,252 - Chang , et al. | 2020-05-26 |
Isolation, Detection, Diagnosis And/or Characterization Of Circulating Trop-2-positive Cancer Cells
App 20190369103 - Goldenberg; David M. ; et al. | 2019-12-05 |
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
Grant 10,436,788 - Goldenberg , et al. O | 2019-10-08 |
Murine, chimeric, humanized or human anti-TNF-alpha antibodies
Grant 10,385,139 - Goldenberg , et al. A | 2019-08-20 |
Combination Of Abcg2 Inhibitors With Sacituzumab Govitecan (immu-132) Overcomes Resistance To Sn-38 In Trop-2 Expressing Cancers
App 20190248917 - Chang; Chien-Hsing ; et al. | 2019-08-15 |
Isolated nucleic acid encoding an anti-IGF-1R antibody
Grant 10,377,829 - Chang , et al. A | 2019-08-13 |
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,308,688 - Chang , et al. | 2019-06-04 |
Combination Therapy For Inducing Immune Response To Disease
App 20190142939 - Chang; Chien-Hsing ; et al. | 2019-05-16 |
Combination therapy for inducing immune response to disease
Grant 10,245,321 - Chang , et al. | 2019-04-02 |
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,239,938 - Chang , et al. | 2019-03-26 |
Humanized Anti-HLA-DR Antibodies
App 20190071503 - Goldenberg; David M. ; et al. | 2019-03-07 |
T-cell redirecting bispecific antibodies for treatment of disease
Grant 10,183,992 - Chang , et al. Ja | 2019-01-22 |
Humanized anti-HLA-DR antibodies
Grant 10,174,114 - Goldenberg , et al. J | 2019-01-08 |
Nucleic acids encoding chimeric and humanized anti-histone antibodies
Grant 10,160,801 - Chang , et al. Dec | 2018-12-25 |
Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors
Grant 10,131,712 - Rossi , et al. November 20, 2 | 2018-11-20 |
Combination therapy for inducing immune response to disease
Grant 10,111,954 - Chang , et al. October 30, 2 | 2018-10-30 |
Chimeric and Humanized Anti-Histone Antibodies
App 20180298089 - Chang; Chien-Hsing ; et al. | 2018-10-18 |
Chimeric and humanized anti-histone antibodies
Grant 10,040,848 - Chang , et al. August 7, 2 | 2018-08-07 |
Interferon lambda-antibody complexes
Grant 10,022,427 - Chang , et al. July 17, 2 | 2018-07-17 |
Bispecific Antibodies that Neutralize TNF-alpha and IL-6: Novel Therapeutic Agents for Autoimmune Disease
App 20180186898 - Goldenberg; David M. ; et al. | 2018-07-05 |
Chimeric and Humanized Anti-Histone Antibodies
App 20180171003 - Chang; Chien-Hsing ; et al. | 2018-06-21 |
T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines
Grant 9,993,547 - Stenler , et al. June 12, 2 | 2018-06-12 |
Isolation, Detection, Diagnosis And/or Characterization Of Circulating Trop-2-positive Cancer Cells
App 20180149657 - Goldenberg; David M. ; et al. | 2018-05-31 |
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,963,507 - Chang , et al. May 8, 2 | 2018-05-08 |
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20180118846 - Chang; Chien-Hsing ; et al. | 2018-05-03 |
Humanized anti-CD22 antibody
Grant 9,944,703 - Chang , et al. April 17, 2 | 2018-04-17 |
Tetrameric cytokines with improved biological activity
Grant 9,931,413 - Chang , et al. April 3, 2 | 2018-04-03 |
Murine, chimeric, humanized or human anti-IL-6 antibodies
Grant 9,932,413 - Goldenberg , et al. April 3, 2 | 2018-04-03 |
Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors
App 20180079816 - Chang; Chien-Hsing ; et al. | 2018-03-22 |
Methods for treating ischemic stroke using chimeric and humanized anti-histone antibodies
Grant 9,920,116 - Chang , et al. March 20, 2 | 2018-03-20 |
Novel Anti-pd-1 Checkpoint Inhibitor Antibodies That Block Binding Of Pd-l1 To Pd-1
App 20180051085 - Chang; Chien-Hsing ; et al. | 2018-02-22 |
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,879,088 - Chang , et al. January 30, 2 | 2018-01-30 |
Chimeric and Humanized Anti-Histone Antibodies
App 20180022796 - Chang; Chien-Hsing ; et al. | 2018-01-25 |
PEGylation by the dock and lock (DNL) technique
Grant 9,872,920 - Chang , et al. January 23, 2 | 2018-01-23 |
Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
Grant 9,862,770 - Chang , et al. January 9, 2 | 2018-01-09 |
Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
Grant 9,839,689 - Chang , et al. December 12, 2 | 2017-12-12 |
Crosslinking Of Cd22 By Epratuzumab Triggers Bcr Signaling And Caspase-dependent Apoptosis In Hematopoietic Cancer Cells
App 20170326238 - Chang; Chien-Hsing ; et al. | 2017-11-16 |
Methods Of Treating Cancer With Antibodies That Target The Insulin-like Growth Factor Type I Receptor (igf-1r)
App 20170320952 - Chang; Chien-Hsing ; et al. | 2017-11-09 |
Methods for treating thrombosis using chimeric and humanized anti-histone antibodies
Grant 9,809,646 - Chang , et al. November 7, 2 | 2017-11-07 |
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells
Grant 9,797,907 - Goldenberg , et al. October 24, 2 | 2017-10-24 |
Combination Therapy For Inducing Immune Response To Disease
App 20170281767 - Chang; Chien-Hsing ; et al. | 2017-10-05 |
Bispecific Antibodies That Neutralize Both Tnf-alpha And Il-6: Novel Therapeutic Agent For Autoimmune Disease
App 20170283511 - Goldenberg; David M. ; et al. | 2017-10-05 |
Combination Therapy With T-cell Redirecting Bispecific Antibodies And Checkpoint Inhibitors
App 20170275375 - Rossi; Edmund A. ; et al. | 2017-09-28 |
Humanized Anti-cd22 Antibody
App 20170275363 - Chang; Chien-Hsing ; et al. | 2017-09-28 |
Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
Grant 9,757,458 - Chang , et al. September 12, 2 | 2017-09-12 |
Class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
Grant 9,751,948 - Chang , et al. September 5, 2 | 2017-09-05 |
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20170247417 - Chang; Chien-Hsing ; et al. | 2017-08-31 |
T20 Constructs For Anti-hiv (human Immunodeficiency Virus) Therapy And/or Vaccines
App 20170246291 - Stenler; Sofia ; et al. | 2017-08-31 |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 9,737,617 - Chang , et al. August 22, 2 | 2017-08-22 |
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20170226219 - Chang; Chien-Hsing ; et al. | 2017-08-10 |
Combination Of Abcg2 Inhibitors With Sacituzumab Govitecan (immu-132) Overcomes Resistance To Sn-38 In Trop-2 Expressing Cancers
App 20170224837 - Chang; Chien-Hsing ; et al. | 2017-08-10 |
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20170226205 - Chang; Chien-Hsing ; et al. | 2017-08-10 |
Methods for Treating Thrombosis Using Chimeric and Humanized Anti-Histone Antibodies
App 20170218059 - Chang; Chien-Hsing ; et al. | 2017-08-03 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 9,707,300 - Govindan , et al. July 18, 2 | 2017-07-18 |
Humanized anti-CD22 antibody
Grant 9,701,748 - Chang , et al. July 11, 2 | 2017-07-11 |
T20 constructs for anti-HIV (human immunodeficiency virus) therapy and/or vaccines
Grant 9,687,547 - Stenler , et al. June 27, 2 | 2017-06-27 |
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20170173167 - Goldenberg; David M. ; et al. | 2017-06-22 |
Combination therapy for inducing immune response to disease
Grant 9,682,143 - Chang , et al. June 20, 2 | 2017-06-20 |
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20170166651 - Chang; Chien-Hsing ; et al. | 2017-06-15 |
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,670,286 - Chang , et al. June 6, 2 | 2017-06-06 |
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,663,576 - Chang , et al. May 30, 2 | 2017-05-30 |
Methods for treating sepsis using chimeric and humanized anti-histone antibodies
Grant 9,657,093 - Chang , et al. May 23, 2 | 2017-05-23 |
Anti-Pancreatic Cancer Antibodies
App 20170137534 - Goldenberg; David M. ; et al. | 2017-05-18 |
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20170121692 - Chang; Chien-Hsing ; et al. | 2017-05-04 |
Dock-and-Lock (DNL) Complexes for Disease Therapy
Grant 9,623,115 - Chang , et al. April 18, 2 | 2017-04-18 |
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock
Grant 9,617,531 - Chang , et al. April 11, 2 | 2017-04-11 |
Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use
App 20170088635 - Chang; Chien-Hsing ; et al. | 2017-03-30 |
Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
App 20170088619 - Chang; Chien-Hsing ; et al. | 2017-03-30 |
Anti-pancreatic cancer antibodies
Grant 9,599,619 - Goldenberg , et al. March 21, 2 | 2017-03-21 |
Humanized Anti-HLA-DR Antibodies
App 20170066828 - Goldenberg; David M. ; et al. | 2017-03-09 |
Tetrameric Cytokines with Improved Biological Activity
App 20170056516 - Chang; Chien-Hsing ; et al. | 2017-03-02 |
Electric pencil sharpener with a replaceable cutter assembly
Grant 9,555,661 - Cheng , et al. January 31, 2 | 2017-01-31 |
Combination Therapy For Inducing Immune Response To Disease
App 20170021017 - Chang; Chien-Hsing ; et al. | 2017-01-26 |
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20170022274 - Chang; Chien-Hsing ; et al. | 2017-01-26 |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
Grant 9,550,838 - Chang , et al. January 24, 2 | 2017-01-24 |
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 9,540,435 - Chang , et al. January 10, 2 | 2017-01-10 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 9,540,618 - Chang , et al. January 10, 2 | 2017-01-10 |
Humanized Anti-cd22 Antibody
App 20160376366 - CHANG; Chien-Hsing ; et al. | 2016-12-29 |
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20160375108 - Chang; Chien-Hsing ; et al. | 2016-12-29 |
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20160368986 - Chang; Chien-Hsing ; et al. | 2016-12-22 |
PEGylation by the Dock and Lock (DNL) Technique
App 20160361435 - Chang; Chien-Hsing ; et al. | 2016-12-15 |
Disease Therapy With Chimeric Antigen Receptor (car) Constructs And T Cells (car-t) Or Nk Cells (car-nk) Expressing Car Constructs
App 20160361360 - Chang; Chien-Hsing ; et al. | 2016-12-15 |
Dock-and-Lock (DNL) Vaccines for Cancer Therapy
App 20160361405 - Chang; Chien-Hsing ; et al. | 2016-12-15 |
Humanized anti-CD22 antibody
Grant 9,518,115 - Chang , et al. December 13, 2 | 2016-12-13 |
Antibodies Reactive With An Epitope Located In The N-terminal Region Of Muc5ac Comprising Cysteine-rich Subdomain 2 (cys2)
App 20160347857 - Liu; Donglin ; et al. | 2016-12-01 |
T20 Constructs For Anti-hiv (human Immunodeficiency Virus) Therapy And/or Vaccines
App 20160346380 - Stenler; Sofia ; et al. | 2016-12-01 |
Multimeric Complexes with Improved in Vivo Stability, Pharmacokinetics and Efficacy
App 20160340443 - Rossi; Edmund A. ; et al. | 2016-11-24 |
Tetrameric cytokines with improved biological activity
Grant 9,498,542 - Chang , et al. November 22, 2 | 2016-11-22 |
Methods Of Treating Cancer With Antibodies That Target The Insulin-like Growth Factor Type I Receptor (igf-1r)
App 20160333098 - Chang; Chien-Hsing ; et al. | 2016-11-17 |
Dock-and-Lock (DNL) Complexes for delivery of interference RNA
Grant 9,492,561 - Chang , et al. November 15, 2 | 2016-11-15 |
Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
Grant 9,481,878 - Chang , et al. November 1, 2 | 2016-11-01 |
Bispecific Antibodies That Neutralize Both Tnf-alpha And Il-6: Novel Therapeutic Agent For Autoimmune Disease
App 20160311931 - Goldenberg; David M. ; et al. | 2016-10-27 |
Isolation, Detection, Diagnosis And/or Characterization Of Circulating Trop-2-positive Cancer Cells
App 20160313339 - Goldenberg; David M. ; et al. | 2016-10-27 |
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,475,883 - Chang , et al. October 25, 2 | 2016-10-25 |
Tumor Therapy By Bispecific Antibody Pretargeting
App 20160287732 - Boerman; Otto C. ; et al. | 2016-10-06 |
Dock-and-lock (DNL) vaccines for cancer therapy
Grant 9,457,072 - Chang , et al. October 4, 2 | 2016-10-04 |
PEGylation by the dock and lock (DNL) technique
Grant 9,457,100 - Chang , et al. October 4, 2 | 2016-10-04 |
Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
Grant 9,452,228 - Liu , et al. September 27, 2 | 2016-09-27 |
Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
Grant 9,446,123 - Rossi , et al. September 20, 2 | 2016-09-20 |
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20160264678 - Chang; Chien-Hsing ; et al. | 2016-09-15 |
Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
Grant 9,441,043 - Chang , et al. September 13, 2 | 2016-09-13 |
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20160257947 - Chang; Chien-Hsing ; et al. | 2016-09-08 |
Therapeutic Use Of Anti-cd22 Antibodies For Inducing Trogocytosis
App 20160251444 - Chang; Chien-Hsing ; et al. | 2016-09-01 |
Delivery System For Cytotoxic Drugs By Bispecific Antibody Pretargeting
App 20160250350 - McBride; William J. ; et al. | 2016-09-01 |
Combination Therapy With Anti-CD74 and Anti-CD20 Antibodies Provides Enhanced Toxicity to B-Cell Diseases
App 20160243226 - Chang; Chien-Hsing ; et al. | 2016-08-25 |
Bispecific antibodies that neutralize both TNF-.alpha. and IL-6: novel therapeutic agent for autoimmune disease
Grant 9,416,197 - Goldenberg , et al. August 16, 2 | 2016-08-16 |
Disease therapy by inducing immune response to Trop-2 expressing cells
Grant 9,382,329 - Chang , et al. July 5, 2 | 2016-07-05 |
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20160176980 - Chang; Chien-Hsing ; et al. | 2016-06-23 |
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20160176968 - Chang; Chien-Hsing ; et al. | 2016-06-23 |
Class I anti-CEA antibodies and uses thereof
Grant 9,371,393 - Hansen , et al. June 21, 2 | 2016-06-21 |
Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases
Grant 9,359,443 - Chang , et al. June 7, 2 | 2016-06-07 |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
Grant 9,352,036 - McBride , et al. May 31, 2 | 2016-05-31 |
Chimeric and Humanized Anti-Histone Antibodies
App 20160130333 - Chang; Chien-Hsing ; et al. | 2016-05-12 |
Interferon Lambda-antibody Complexes
App 20160129086 - Chang; Chien-Hsing ; et al. | 2016-05-12 |
T-cell redirecting bispecific antibodies for treatment of disease
Grant 9,315,567 - Chang , et al. April 19, 2 | 2016-04-19 |
Dock-and-Lock (DNL) Constructs for Human Immunodeficiency Virus (HIV) Therapy
App 20160089449 - Chang; Chien-Hsing ; et al. | 2016-03-31 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20160090413 - Liu; Donglin ; et al. | 2016-03-31 |
Methods of treating rapidly progressive glomerulonephritis using chimeric and humanized anti-histone H4 antibodies
Grant 9,278,129 - Chang , et al. March 8, 2 | 2016-03-08 |
Identification of Cancer Genes by In-Vivo Fusion of Human Cancer Cells and Animal Cells
App 20160060707 - Goldenberg; David M. ; et al. | 2016-03-03 |
Interferon lambada-antibody complexes
Grant 9,272,029 - Chang , et al. March 1, 2 | 2016-03-01 |
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20160032003 - Chang; Chien-Hsing ; et al. | 2016-02-04 |
Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
Grant 9,248,184 - Chang , et al. February 2, 2 | 2016-02-02 |
Humanized Anti-HLA-DR Antibodies
App 20160024212 - Goldenberg; David M. ; et al. | 2016-01-28 |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
Grant 9,238,084 - Liu , et al. January 19, 2 | 2016-01-19 |
Crosslinking Of Cd22 By Epratuzumab Triggers Bcr Signaling And Caspase-dependent Apoptosis In Hematopoietic Cancer Cells
App 20160000915 - Chang; Chien-Hsing ; et al. | 2016-01-07 |
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20150374846 - Chang; Chien-Hsing ; et al. | 2015-12-31 |
Humanized Anti-cd22 Antibody
App 20150344573 - Chang; Chien-Hsing ; et al. | 2015-12-03 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20150343087 - Hansen; Hans J. ; et al. | 2015-12-03 |
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
Grant 9,192,664 - Chang , et al. November 24, 2 | 2015-11-24 |
Humanized anti-HLA-DR antibodies
Grant 9,187,561 - Goldenberg , et al. November 17, 2 | 2015-11-17 |
Antibodies Reactive With An Epitope Located In The N-terminal Region Of Muc5ac Comprising Cysteine-rich Subdomain 2 (cys2)
App 20150315289 - Liu; Donglin ; et al. | 2015-11-05 |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 9,169,470 - Chang , et al. October 27, 2 | 2015-10-27 |
Flat-clinch stapler having a buffering device
Grant 9,149,921 - Chang October 6, 2 | 2015-10-06 |
Humanized anti-CD22 antibody
Grant 9,139,649 - Chang , et al. September 22, 2 | 2015-09-22 |
Humanized Rfb4 Anti-cd22 Antibody
App 20150239974 - Chang; Chien-Hsing ; et al. | 2015-08-27 |
Combination Therapy For Inducing Immune Response To Disease
App 20150231241 - Chang; Chien-Hsing ; et al. | 2015-08-20 |
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20150224192 - Goldenberg; David M. ; et al. | 2015-08-13 |
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
App 20150183880 - Chang; Chien-Hsing ; et al. | 2015-07-02 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20150165076 - Liu; Donglin ; et al. | 2015-06-18 |
Humanized L243 Antibodies
App 20150166659 - Goldenberg; David M. ; et al. | 2015-06-18 |
Anti-cd74 Immunoconjugates And Methods Of Use
App 20150166669 - HANSEN; Hans J. ; et al. | 2015-06-18 |
Chimeric And Humanized Anti-histone Antibodies
App 20150150969 - Chang; Chien-Hsing ; et al. | 2015-06-04 |
Disease Therapy By Inducing Immune Response To Trop-2 Expressing Cells
App 20150132217 - Chang; Chien-Hsing ; et al. | 2015-05-14 |
Anti-Pancreatic Cancer Antibodies
App 20150132768 - Goldenberg; David M. ; et al. | 2015-05-14 |
Bispecific Antibodies That Neutralize Both Tnf-alpha And Il-6: Novel Therapeutic Agent For Autoimmune Disease
App 20150125450 - Goldenberg; David M. ; et al. | 2015-05-07 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20150111279 - Hansen; Hans J. ; et al. | 2015-04-23 |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
Grant 9,005,613 - Liu , et al. April 14, 2 | 2015-04-14 |
Humanized L243 antibodies
Grant 8,992,917 - Goldenberg , et al. March 31, 2 | 2015-03-31 |
Dye Conjugated Peptides for Fluorescent Imaging
App 20150086482 - Regino; Celeste Aida S. ; et al. | 2015-03-26 |
Anti-CD74 immunoconjugates and methods of use
Grant 8,986,699 - Hansen , et al. March 24, 2 | 2015-03-24 |
Chimeric and humanized anti-histone antibodies
Grant 8,987,421 - Chang , et al. March 24, 2 | 2015-03-24 |
Anti-pancreatic cancer antibodies
Grant 8,974,784 - Goldenberg , et al. March 10, 2 | 2015-03-10 |
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20150056680 - Chang; Chien-Hsing ; et al. | 2015-02-26 |
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20150050715 - Chang; Chien-Hsing ; et al. | 2015-02-19 |
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20150037283 - Chang; Chien-Hsing ; et al. | 2015-02-05 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20150038686 - Govindan; Serengulam V. ; et al. | 2015-02-05 |
Class I anti-CEA antibodies and uses thereof
Grant 8,945,554 - Hansen , et al. February 3, 2 | 2015-02-03 |
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20150023870 - Chang; Chien-Hsing ; et al. | 2015-01-22 |
Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use
App 20150024458 - Chang; Chien-Hsing ; et al. | 2015-01-22 |
Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors
App 20150024459 - Chang; Chien-Hsing ; et al. | 2015-01-22 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 8,932,593 - Chang , et al. January 13, 2 | 2015-01-13 |
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20150010982 - Chang; Chien-Hsing ; et al. | 2015-01-08 |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
Grant 8,906,378 - Chang , et al. December 9, 2 | 2014-12-09 |
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 8,906,377 - Chang , et al. December 9, 2 | 2014-12-09 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,889,410 - Goldenberg , et al. November 18, 2 | 2014-11-18 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,889,835 - Govindan , et al. November 18, 2 | 2014-11-18 |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
Grant 8,883,160 - Chang , et al. November 11, 2 | 2014-11-11 |
Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
Grant 8,883,162 - Chang , et al. November 11, 2 | 2014-11-11 |
Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 8,871,216 - Chang , et al. October 28, 2 | 2014-10-28 |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 8,865,176 - Chang , et al. October 21, 2 | 2014-10-21 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20140308278 - Hansen; Hans J. ; et al. | 2014-10-16 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20140308703 - Goldenberg; David M. ; et al. | 2014-10-16 |
Anti-Pancreatic Cancer Antibodies
App 20140294722 - Goldenberg; David M. ; et al. | 2014-10-02 |
Nucleic acids encoding polyvalent protein complexes
Grant 8,829,175 - Rossi , et al. September 9, 2 | 2014-09-09 |
Anti-pancreatic cancer antibodies
Grant 8,821,868 - Goldenberg , et al. September 2, 2 | 2014-09-02 |
Chimeric And Humanized Anti-histone Antibodies
App 20140234209 - Chang; Chien-Hsing ; et al. | 2014-08-21 |
Anti-mucin Antibodies For Early Detection And Treatment Of Pancreatic Cancer
App 20140227179 - Liu; Donglin ; et al. | 2014-08-14 |
Humanized Anti-HLA-DR Antibodies
App 20140227178 - Goldenberg; David M. ; et al. | 2014-08-14 |
Therapeutic Use Of Anti-cd22 Antibodies For Inducing Trogocytosis
App 20140212425 - Chang; Chien-Hsing ; et al. | 2014-07-31 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,771,987 - Goldenberg , et al. July 8, 2 | 2014-07-08 |
Class I anti-CEA antibodies and uses thereof
Grant 8,771,690 - Hansen , et al. July 8, 2 | 2014-07-08 |
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20140170065 - Goldenberg; David M. ; et al. | 2014-06-19 |
Tetrameric Cytokines with Improved Biological Activity
App 20140161766 - Chang; Chien-Hsing ; et al. | 2014-06-12 |
Humanized L243 Antibodies
App 20140140924 - Goldenberg; David M. ; et al. | 2014-05-22 |
Humanized anti-HLA-DR antibodies
Grant 8,722,047 - Goldenberg , et al. May 13, 2 | 2014-05-13 |
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
Grant 8,697,080 - Goldenberg , et al. April 15, 2 | 2014-04-15 |
Combination Therapy For Inducing Immune Response To Disease
App 20140099254 - Chang; Chien-Hsing ; et al. | 2014-04-10 |
Delivery System For Cytotoxic Drugs By Bispecific Antibody Pretargeting
App 20140086832 - McBride; William J. ; et al. | 2014-03-27 |
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
App 20140086830 - Chang; Chien-Hsing ; et al. | 2014-03-27 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20140079629 - Hansen; Hans J. ; et al. | 2014-03-20 |
Flat-clinch Stapler Having A Buffering Device
App 20140054352 - Chang; Chien-Hsing | 2014-02-27 |
T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
App 20140050660 - Chang; Chien-Hsing ; et al. | 2014-02-20 |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
Grant 8,652,484 - McBride , et al. February 18, 2 | 2014-02-18 |
Novel Strategies for Improved Cancer Vaccines
App 20140045242 - Chang; Chien-Hsing ; et al. | 2014-02-13 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20140038284 - Goldenberg; David M. ; et al. | 2014-02-06 |
Anti-Pancreatic Cancer Antibodies
App 20140037543 - Goldenberg; David M. ; et al. | 2014-02-06 |
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20140038261 - Chang; Chien-Hsing ; et al. | 2014-02-06 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20130344071 - Hansen; Hans J. ; et al. | 2013-12-26 |
Humanized L243 antibodies
Grant 8,613,903 - Goldenberg , et al. December 24, 2 | 2013-12-24 |
Class I anti-CEA antibodies and uses thereof
Grant 8,603,479 - Hansen , et al. December 10, 2 | 2013-12-10 |
Multimeric Complexes with Improved in Vivo Stability, Pharmacokinetics and Efficacy
App 20130323204 - Rossi; Edmund A. ; et al. | 2013-12-05 |
Tetrameric cytokines with improved biological activity
Grant 8,597,659 - Chang , et al. December 3, 2 | 2013-12-03 |
Stapler With Leg-flattening And Anvil-limiting Capability
App 20130306700 - CHANG; Chien-Hsing | 2013-11-21 |
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20130295005 - Chang; Chien-Hsing ; et al. | 2013-11-07 |
Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA
App 20130289244 - Chang; Chien-Hsing ; et al. | 2013-10-31 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,569,054 - Goldenberg , et al. October 29, 2 | 2013-10-29 |
Dock-and-Lock (DNL) Constructs for Human Immunodeficiency Virus (HIV) Therapy
App 20130280250 - Chang; Chien-Hsing ; et al. | 2013-10-24 |
Strategies for improved cancer vaccines
Grant 8,562,988 - Chang , et al. October 22, 2 | 2013-10-22 |
Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
Grant 8,551,480 - Chang , et al. October 8, 2 | 2013-10-08 |
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20130217091 - Chang; Chien-Hsing ; et al. | 2013-08-22 |
Electric Pencil Sharpener With A Replaceable Cutter Assembly
App 20130186517 - Cheng; Che-Chang ; et al. | 2013-07-25 |
Anti-pancreatic cancer antibodies
Grant 8,491,896 - Goldenberg , et al. July 23, 2 | 2013-07-23 |
Dock-and-lock (DNL) complexes for delivery of interference RNA
Grant 8,491,914 - Chang , et al. July 23, 2 | 2013-07-23 |
PEGylation by the Dock and Lock (DNL) Technique
App 20130177532 - Chang; Chien-Hsing ; et al. | 2013-07-11 |
Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
Grant 8,481,041 - Chang , et al. July 9, 2 | 2013-07-09 |
Anti-CD74 Immunoconjugates and Methods of Use
App 20130171064 - Hansen; Hans J. ; et al. | 2013-07-04 |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
Grant 8,475,794 - Chang , et al. July 2, 2 | 2013-07-02 |
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20130164816 - Chang; Chien-Hsing ; et al. | 2013-06-27 |
Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
App 20130164214 - Chang; Chien-Hsing ; et al. | 2013-06-27 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20130164783 - Goldenberg; David M. ; et al. | 2013-06-27 |
Class I anti-CEA antibodies and uses thereof
Grant 8,470,994 - Hansen , et al. June 25, 2 | 2013-06-25 |
Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting
App 20130143296 - McBride; William J. ; et al. | 2013-06-06 |
Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis
App 20130142787 - Chang; Chien-Hsing ; et al. | 2013-06-06 |
Targeting Interferon-lambda With Antibodies Potently Enhances Anti-tumor And Anti-viral Activities
App 20130136718 - Chang; Chien-Hsing ; et al. | 2013-05-30 |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
Grant 8,435,539 - McBride , et al. May 7, 2 | 2013-05-07 |
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO
Grant 8,435,540 - Chang , et al. May 7, 2 | 2013-05-07 |
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20130109073 - Chang; Chien-Hsing ; et al. | 2013-05-02 |
Multivalent Antibody Complexes Targeting IGF-1R Show Potent Toxicity Against Solid Tumors
App 20130095033 - Chang; Chien-Hsing ; et al. | 2013-04-18 |
Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants
App 20130078263 - Sawada; Tokihiko ; et al. | 2013-03-28 |
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20130078183 - Chang; Chien-Hsing ; et al. | 2013-03-28 |
Structural Variants of Antibodies for Improved Therapeutic Characteristics
App 20130078182 - Goldenberg; David M. ; et al. | 2013-03-28 |
Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
App 20130071406 - Goldenberg; David M. ; et al. | 2013-03-21 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20130072659 - Govindan; Serengulam V. ; et al. | 2013-03-21 |
Anti-CD74 immunoconjugates and methods of use
Grant 8,383,081 - Hansen , et al. February 26, 2 | 2013-02-26 |
Dye Conjugated Peptides for Fluorescent Imaging
App 20130039861 - Regino; Celeste Aida S. ; et al. | 2013-02-14 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,372,603 - Goldenberg , et al. February 12, 2 | 2013-02-12 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20130034492 - Hansen; Hans J. ; et al. | 2013-02-07 |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
Grant 8,349,332 - Chang , et al. January 8, 2 | 2013-01-08 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,338,140 - Govindan , et al. December 25, 2 | 2012-12-25 |
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
Grant 8,333,971 - Goldenberg , et al. December 18, 2 | 2012-12-18 |
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20120276100 - Chang; Chien-Hsing ; et al. | 2012-11-01 |
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20120276608 - Chang; Chien-Hsing ; et al. | 2012-11-01 |
Structural variants of antibodies for improved therapeutic characteristics
Grant 8,287,864 - Goldenberg , et al. October 16, 2 | 2012-10-16 |
Class I anti-CEA antibodies and uses thereof
Grant 8,287,865 - Hansen , et al. October 16, 2 | 2012-10-16 |
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
Grant 8,282,934 - Chang , et al. October 9, 2 | 2012-10-09 |
PEGylation by the dock and lock (DNL) technique
Grant 8,277,817 - Chang , et al. October 2, 2 | 2012-10-02 |
Design and Construction of Novel Multivalent Antibodies
App 20120237442 - Rossi; Edmund A. ; et al. | 2012-09-20 |
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20120225032 - Chang; Chien-Hsing ; et al. | 2012-09-06 |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 8,246,960 - Chang , et al. August 21, 2 | 2012-08-21 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20120196326 - Goldenberg; David M. ; et al. | 2012-08-02 |
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20120196346 - Chang; Chien-Hsing ; et al. | 2012-08-02 |
Multivalent immunoglobulin-based bioactive assemblies
Grant 8,211,440 - Chang , et al. July 3, 2 | 2012-07-03 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 8,163,291 - Chang , et al. April 24, 2 | 2012-04-24 |
Stem Cell Targeting with Dock-and-Lock (DNL) Complexes
App 20120093769 - Chang; Chien-Hsing ; et al. | 2012-04-19 |
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
Grant 8,158,129 - Chang , et al. April 17, 2 | 2012-04-17 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20120088299 - Goldenberg; David M. ; et al. | 2012-04-12 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,153,433 - Goldenberg , et al. April 10, 2 | 2012-04-10 |
Dock-and-Lock (DNL) Constructs for Human Immunodeficiency Virus (HIV) Therapy
App 20120082685 - Chang; Chien-Hsing ; et al. | 2012-04-05 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20120040431 - Govindan; Serengulam V. ; et al. | 2012-02-16 |
Methods and compositions for administering therapeutic and diagnostic agents
Grant 8,097,252 - McBride , et al. January 17, 2 | 2012-01-17 |
Tetrameric Cytokines with Improved Biological Activity
App 20120009149 - Chang; Chien-Hsing ; et al. | 2012-01-12 |
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20110318306 - Chang; Chien-Hsing ; et al. | 2011-12-29 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 8,076,140 - Goldenberg , et al. December 13, 2 | 2011-12-13 |
Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
App 20110300066 - Chang; Chien-Hsing ; et al. | 2011-12-08 |
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20110300105 - Chang; Chien-Hsing ; et al. | 2011-12-08 |
Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
Grant 8,067,006 - Govindan , et al. November 29, 2 | 2011-11-29 |
Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
App 20110274704 - Chang; Chien-Hsing ; et al. | 2011-11-10 |
Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases
App 20110256053 - Chang; Chien-Hsing ; et al. | 2011-10-20 |
Tetrameric cytokines with improved biological activity
Grant 8,034,352 - Chang , et al. October 11, 2 | 2011-10-11 |
Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
App 20110243841 - Chang; Chien-Hsing ; et al. | 2011-10-06 |
PEGylation by the Dock and Lock (DNL) Technique
App 20110236352 - Chang; Chien-Hsing ; et al. | 2011-09-29 |
Structural Variants Of Antibodies For Improved Therapeutic Characteristics
App 20110236304 - GOLDENBERG; David M. ; et al. | 2011-09-29 |
Methods for Protein Expression in Mammalian Cells in Serum-Free Medium
App 20110236404 - Goldenberg; David M. ; et al. | 2011-09-29 |
Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
Grant 8,003,111 - Chang , et al. August 23, 2 | 2011-08-23 |
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20110195020 - Chang; Chien-Hsing ; et al. | 2011-08-11 |
Dock-and-Lock (DNL) Vaccines for Cancer Therapy
App 20110189083 - Chang; Chien-Hsing ; et al. | 2011-08-04 |
Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis
App 20110189268 - Taylor; Alice P. ; et al. | 2011-08-04 |
PEGylation by the dock and lock (DNL) technique
Grant 7,981,398 - Chang , et al. July 19, 2 | 2011-07-19 |
Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use
App 20110158905 - Goldenberg; David M. ; et al. | 2011-06-30 |
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20110143417 - Chang; Chien-Hsing ; et al. | 2011-06-16 |
Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA
App 20110123436 - Chang; Chien-Hsing ; et al. | 2011-05-26 |
Methods and Compositions for Administering Therapeutic and Diagnostic Agents
App 20110117010 - McBride; William J. ; et al. | 2011-05-19 |
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20110110851 - Chang; Chien-Hsing ; et al. | 2011-05-12 |
Inhibition of placenta growth factor (PlGF) mediated metastasis and/or angiogenesis
Grant 7,932,212 - Taylor , et al. April 26, 2 | 2011-04-26 |
Structural variants of antibodies for improved therapeutic characteristics
Grant 7,919,273 - Goldenberg , et al. April 5, 2 | 2011-04-05 |
Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting
App 20110076233 - McBride; William J. ; et al. | 2011-03-31 |
Class I Anti-CEA Antibodies and Uses Thereof
App 20110064653 - Hansen; Hans J. ; et al. | 2011-03-17 |
Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
Grant 7,906,118 - Chang , et al. March 15, 2 | 2011-03-15 |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 7,906,121 - Chang , et al. March 15, 2 | 2011-03-15 |
Dock-and-lock (DNL) vaccines for cancer therapy
Grant 7,901,680 - Chang , et al. March 8, 2 | 2011-03-08 |
Methods and compositions for administering therapeutic and diagnostic agents
Grant 7,892,547 - McBride , et al. February 22, 2 | 2011-02-22 |
Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
App 20110020273 - Chang; Chien-Hsing ; et al. | 2011-01-27 |
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 7,871,622 - Chang , et al. January 18, 2 | 2011-01-18 |
Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
App 20110008251 - Chang; Chien-Hsing ; et al. | 2011-01-13 |
Multivalent immunoglobulin-based bioactive assemblies
Grant 7,858,070 - Chang , et al. December 28, 2 | 2010-12-28 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20100311162 - Goldenberg; David M. ; et al. | 2010-12-09 |
Anti-CD74 Immunoconjugates and Methods of Use
App 20100266496 - Hansen; Hans J. ; et al. | 2010-10-21 |
PEGylation by the Dock and Lock (DNL) Technique
App 20100261885 - Chang; Chien-Hsing ; et al. | 2010-10-14 |
Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
App 20100233779 - Govindan; Serengulam V. ; et al. | 2010-09-16 |
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
App 20100226884 - Chang; Chien-Hsing ; et al. | 2010-09-09 |
Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
App 20100221210 - Chang; Chien-Hsing ; et al. | 2010-09-02 |
Mammalian cell lines for increasing longevity and protein yield from cell culture
Grant 7,785,880 - Goldenberg , et al. August 31, 2 | 2010-08-31 |
Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis
App 20100216662 - Taylor; Alice P. ; et al. | 2010-08-26 |
Humanized Anti-HLA-DR Antibodies
App 20100196266 - Goldenberg; David M. ; et al. | 2010-08-05 |
Humanized L243 Antibodies
App 20100196267 - Goldenberg; David M. ; et al. | 2010-08-05 |
Novel Strategies for Improved Cancer Vaccines
App 20100189641 - Chang; Chien-Hsing ; et al. | 2010-07-29 |
Tetrameric Cytokines with Improved Biological Activity
App 20100189689 - Chang; Chien-Hsing ; et al. | 2010-07-29 |
Dock-and-Lock (DNL) Vaccines for Cancer Therapy
App 20100068137 - Chang; Chien-Hsing ; et al. | 2010-03-18 |
PEGylation by the dock and lock (DNL) technique
Grant 7,666,400 - Chang , et al. February 23, 2 | 2010-02-23 |
Structural Variants of Antibodies for Improved Therapeutic Characteristics
App 20100040541 - Goldenberg; David M. ; et al. | 2010-02-18 |
Structural Variants of Antibodies for Improved Therapeutic Characteristics
App 20100034738 - Goldenberg; David M. ; et al. | 2010-02-11 |
Inhibition of placenta growth factor (PLGF) mediated metastasis and/or angiogenesis
Grant 7,642,239 - Taylor , et al. January 5, 2 | 2010-01-05 |
Anti-Pancreatic Cancer Antibodies
App 20090304580 - Goldenberg; David M. ; et al. | 2009-12-10 |
Multivalent Immunoglobulin-Based Bioactive Assemblies
App 20090269277 - Chang; Chien-Hsing ; et al. | 2009-10-29 |
Methods for protein expression in mammalian cells in serum-free medium
Grant 7,608,425 - Goldenberg , et al. October 27, 2 | 2009-10-27 |
Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
App 20090253179 - Goldenberg; David M. ; et al. | 2009-10-08 |
Fusion Proteins Containing Recombinant Cytotoxic Rnases
App 20090246214 - GOLDENBERG; David M. ; et al. | 2009-10-01 |
Methods and Compositions for Administering Therapeutic and Diagnostic Agents
App 20090238757 - McBride; William J. ; et al. | 2009-09-24 |
Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses
App 20090202433 - Chang; Chien-Hsing ; et al. | 2009-08-13 |
Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
App 20090202487 - Chang; Chien-Hsing ; et al. | 2009-08-13 |
Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
App 20090191225 - Chang; Chien-Hsing ; et al. | 2009-07-30 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
Grant 7,550,143 - Chang , et al. June 23, 2 | 2009-06-23 |
Mammalian cell lines for increasing longevity and protein yield from a cell culture
Grant 7,537,930 - Goldenberg , et al. May 26, 2 | 2009-05-26 |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
Grant 7,534,866 - Chang , et al. May 19, 2 | 2009-05-19 |
Methods and compositions for increasing longevity and protein yield from a cell culture
Grant 7,531,327 - Goldenberg , et al. May 12, 2 | 2009-05-12 |
Multivalent immunoglobulin-based bioactive assemblies
Grant 7,527,787 - Chang , et al. May 5, 2 | 2009-05-05 |
Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium
App 20090111143 - Goldenberg; David M. ; et al. | 2009-04-30 |
Stably tethered structures of defined compositions with multiple functions or binding specificities
Grant 7,521,056 - Chang , et al. April 21, 2 | 2009-04-21 |
| 